ARA-290: Research Summary and How to Judge a Supplier
Erythropoietin-derived 11-mer studied in small neuropathy trials. This profile sets out what is actually published, what a 10mg vial should cost, and the specific documentation to ask for before ordering ARA-290 from any research supplier.
10mg
Typical vial
$55
Lowest tracked
$78
Median price
56
Vendors listing
What ARA-290 is
ARA-290, also called cibinetide, is an 11-amino-acid peptide derived from the tissue-protective domain of erythropoietin, designed to keep the cytoprotective signalling without the haematopoietic effect. It has been through small randomised trials in sarcoidosis-associated small fibre neuropathy with measurable endpoints.
Among the peptides added here it is one of the few with genuine, if small, controlled human data rather than purely preclinical support.
What the evidence base looks like
There is a real published record behind this compound, spread across animal work and a smaller amount of human data, but not enough controlled evidence to support confident claims.
Our library records roughly 34 relevant publications for ARA-290 and grades the evidence as moderate. That grade describes the weight of research, not a judgement about safety or effect, and it is reviewed as new work is published.
Supplier quality: what to check on ARA-290
Its short sequence resembles several inactive fragments, so identity confirmation is worth more than a high purity figure.
The practical checklist is the same on every product but weighted differently here: a batch-matched certificate of analysis, an identity method appropriate to this molecule rather than purity alone, clear peptide content per 10mg vial, and a supplier that will answer a technical question before taking payment.
Typical UK pricing
The lowest price we currently track for a 10mg vial is £54.90, against a market median nearer £78. Compare on price per milligram rather than per vial, because vial sizes across suppliers are rarely identical.
A listing well below the tracked low is worth investigating rather than celebrating. On this compound the cost of doing it properly is largely analytical, and that is the first thing an unusually cheap supplier stops paying for.
Frequently asked
Is ARA-290 approved for human use?
No. Everything listed here is supplied for laboratory research use only, and nothing on this page is medical advice.
How much should ARA-290 cost?
Tracked UK prices start around £54.90 for a 10mg vial, with the market median closer to £78.
What is the single most useful check on ARA-290?
Its short sequence resembles several inactive fragments, so identity confirmation is worth more than a high purity figure.
Search focus for this profile
ara-290 — Tracked monthly searches, difficulty Monitored. Source: Semrush (UK database).
Supporting terms covered: ara-290 review, buy ara-290 uk, ara-290 price, best ara-290 supplier.
Everything below describes published research and market data. Nothing here is medical advice, and none of these compounds are sold or supplied by CheckALab.
More in Neuro
PT-141
Melanocortin agonist with completed randomized human trials on arousal endpoints.
Selank
Anxiolytic peptide with mostly Russian-language clinical literature.
PE-22-28
Spadin analogue studied in rodent models of depression via TREK-1 channel blockade.
Adamax
Adamantane-modified nootropic peptide with very little published data.
Cortagen
Khavinson bioregulator peptide studied in peripheral nerve and cortical tissue models.
Dermorphin
Amphibian-derived opioid heptapeptide studied in receptor pharmacology research.
DSIP
Delta sleep-inducing peptide with an old and inconsistent research record.
Semax
ACTH 4-10 analogue registered as a medicine in Russia and studied in stroke research.